197 related articles for article (PubMed ID: 33038005)
1. General Practitioner Use of Generically Substitutable Inhaler Devices and the Impact of Training on Device Mastery and Maintenance of Correct Inhaler Technique.
Cvetkovski B; Hespe C; Tan R; Kritikos V; Azzi E; Bosnic-Anticevich S
Pulm Ther; 2020 Dec; 6(2):315-331. PubMed ID: 33038005
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of inhaler technique and achievement and maintenance of mastery of budesonide/formoterol Spiromax® compared with budesonide/formoterol Turbuhaler® in adult patients with asthma: the Easy Low Instruction Over Time (ELIOT) study.
Price DB; Thomas V; Richard Dekhuijzen PN; Bosnic-Anticevich S; Roche N; Lavorini F; Raju P; Freeman D; Nicholls C; Small IR; Sims E; Safioti G; Canvin J; Chrystyn H
BMC Pulm Med; 2018 Jun; 18(1):107. PubMed ID: 29954359
[TBL] [Abstract][Full Text] [Related]
3. Inhaler technique mastery and maintenance in healthcare professionals trained on different devices.
Bosnic-Anticevich S; Callan C; Chrystyn H; Lavorini F; Nikolaou V; Kritikos V; Dekhuijzen PNR; Roche N; Bjermer L; Rand C; Zwar N; Price DB
J Asthma; 2018 Jan; 55(1):79-88. PubMed ID: 28332886
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of inhaler handling-errors, inhaler perception and preference with Spiromax, Easyhaler and Turbuhaler devices among healthy Finnish volunteers: a single site, single visit crossover study (Finhaler).
Sandler N; Holländer J; Långström D; Santtila P; Saukkonen A; Torvinen S
BMJ Open Respir Res; 2016; 3(1):e000119. PubMed ID: 27026804
[TBL] [Abstract][Full Text] [Related]
5. Real-life association between inhaler technique, patient preference and asthma control in patients with uncontrolled asthma switched to budesonide/formoterol DuoResp® Spiromax® combination.
Roche N; Aguilaniu B; Paternotte S; Dallery N
J Asthma; 2022 Apr; 59(4):765-774. PubMed ID: 33493074
[No Abstract] [Full Text] [Related]
6. Comparison of correct technique and preference for Spiromax®, Easyhaler® and Turbuhaler®: a single-site, single-visit, crossover study in inhaler-naïve adult volunteers.
Rönmark P; Jagorstrand B; Safioti G; Menon S; Bjermer L
Eur Clin Respir J; 2018; 5(1):1529536. PubMed ID: 30370020
[No Abstract] [Full Text] [Related]
7. Assessment of inhalation errors, training time and patient preference for DuoResp® Spiromax® and Symbicort® Turbuhaler® in patients with asthma and COPD.
Giner J; Villarnovo Cerrillo M; Aboín Sierra J; Casas Herrero L; Patino O; Plaza V
Eur Clin Respir J; 2020 Oct; 8(1):1833411. PubMed ID: 33144930
[TBL] [Abstract][Full Text] [Related]
8. Inhalation characteristics of asthma patients, COPD patients and healthy volunteers with the Spiromax® and Turbuhaler® devices: a randomised, cross-over study.
Azouz W; Chetcuti P; Hosker H; Saralaya D; Chrystyn H
BMC Pulm Med; 2015 May; 15():47. PubMed ID: 25927483
[TBL] [Abstract][Full Text] [Related]
9. Budesonide + formoterol delivered via Spiromax
Lewis A; Torvinen S; Dekhuijzen PNR; Chrystyn H; Melani A; Zöllner Y; Kolbe K; Watson AT; Blackney M; Plich A
Respir Med; 2017 Aug; 129():179-188. PubMed ID: 28732829
[TBL] [Abstract][Full Text] [Related]
10. A randomized, double-blinded, double-dummy efficacy and safety study of budesonide-formoterol Spiromax® compared to budesonide-formoterol Turbuhaler® in adults and adolescents with persistent asthma.
Virchow JC; Rodriguez-Roisin R; Papi A; Shah TP; Gopalan G
BMC Pulm Med; 2016 Mar; 16():42. PubMed ID: 26987997
[TBL] [Abstract][Full Text] [Related]
11. Spiromax, a New Dry Powder Inhaler: Dose Consistency under Simulated Real-World Conditions.
Canonica GW; Arp J; Keegstra JR; Chrystyn H
J Aerosol Med Pulm Drug Deliv; 2015 Oct; 28(5):309-19. PubMed ID: 26352860
[TBL] [Abstract][Full Text] [Related]
12. Onset of action of budesonide/formoterol Spiromax(®) compared with budesonide/formoterol Turbuhaler(®) in patients with COPD.
Cazzola M; Ora J; Di Paolo A; Puxeddu E; Calzetta L; Rogliani P
Pulm Pharmacol Ther; 2016 Aug; 39():48-53. PubMed ID: 27344046
[TBL] [Abstract][Full Text] [Related]
13. Patient Satisfaction and Clinical Outcomes with Budesonide plus Formoterol Spiromax for Asthma and Chronic Obstructive Pulmonary Disease: A Real-World, Observational Trial.
Gillissen A; Gessner C; Hechenbichler K; Herth FJF; Juenemann R; Kanniess F; Kardos P; Lommatzsch M; Schneidereit R; Windisch W
Respiration; 2019; 97(4):292-301. PubMed ID: 30391944
[TBL] [Abstract][Full Text] [Related]
14. Inhaler devices in asthma and COPD patients - a prospective cross-sectional study on inhaler preferences and error rates.
Schreiber J; Sonnenburg T; Luecke E
BMC Pulm Med; 2020 Aug; 20(1):222. PubMed ID: 32819337
[TBL] [Abstract][Full Text] [Related]
15. Narrative Review of the Role of Patient-Reported Outcomes and Inhaler Handling Errors in the Control of Asthma and COPD.
De Simón Gutiérrez R; Castro RP
Curr Allergy Asthma Rep; 2022 Nov; 22(11):151-161. PubMed ID: 36087251
[TBL] [Abstract][Full Text] [Related]
16. Comparison of patient preference and ease of teaching inhaler technique for Pulmicort Turbuhaler versus pressurized metered-dose inhalers.
Welch MJ; Nelson HS; Shapiro G; Bensch GW; Sokol WN; Smith JA; Parasuraman BM
J Aerosol Med; 2004; 17(2):129-39. PubMed ID: 15294063
[TBL] [Abstract][Full Text] [Related]
17. Time Required to Rectify Inhaler Errors Among Experienced Subjects With Faulty Technique.
Melani AS; Bonavia M; Mastropasqua E; Zanforlin A; Lodi M; Martucci P; Scichilone N; Aliani M; Neri M; Sestini P;
Respir Care; 2017 Apr; 62(4):409-414. PubMed ID: 27999149
[TBL] [Abstract][Full Text] [Related]
18. Estimating the economic consequences of an increased medication adherence due to a potential improvement in the inhaler technique with Spiromax
Darbà J; Ramírez G; García-Rivero JL; Mayoralas S; Pascual JF; Vargas D; Bijedic A
Clinicoecon Outcomes Res; 2017; 9():127-137. PubMed ID: 28228660
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.
Brocklebank D; Ram F; Wright J; Barry P; Cates C; Davies L; Douglas G; Muers M; Smith D; White J
Health Technol Assess; 2001; 5(26):1-149. PubMed ID: 11701099
[TBL] [Abstract][Full Text] [Related]
20. Exploring General Practitioners' Preferences and Experience with Respiratory Inhaler Devices.
Cvetkovski B; Hespe C; House R; Kritikos V; Azzi E; Evans J; Srour-Alphonse P; Bosnic-Anticevich S
Pulm Ther; 2022 Sep; 8(3):283-296. PubMed ID: 35908142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
